Related Experiment Video
Updated: Jul 17, 2026

07:41
Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
Published on: February 8, 2022
Device closure of large atrial septal defects: technical considerations
Yun-Ching Fu1, Qi-Ling Cao, Ziyad M Hijazi
1Section of Pediatric Cardiology, Department of Pediatrics, Taichung Veterans General Hospital and National Yang-Ming University, Taichung, Taiwan.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|January 27, 2007
Summary
Transcatheter closure is an alternative to surgery for atrial septal defects. Techniques are reviewed to ensure proper device placement, especially for large defects.
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Transcatheter closure is a common alternative to surgical repair for secundum atrial septal defects (ASDs).
- While closure of small to moderate ASDs is generally straightforward, large ASDs present significant technical challenges for device deployment.
- Securing optimal device position is critical for successful transcatheter ASD closure.
Observation:
- Various techniques can be employed to facilitate device deployment in challenging large ASD cases.
- Specialized delivery sheaths, such as the 'Hausdorf sheath', can aid in device manipulation.
- Alternative deployment strategies include utilizing pulmonary veins for initial positioning or employing adjuncts like dilators/balloons to stabilize the device.
Findings:
- The Hausdorf sheath offers a method for improved device delivery in large ASDs.
- Deployment within the pulmonary veins can assist in achieving correct device seating.
- Using a Judkins right coronary guiding catheter provides an alternative approach for device deployment.
Implications:
- These techniques enhance the feasibility and success rates of transcatheter closure for large atrial septal defects.
- Improved device deployment strategies expand treatment options for patients with complex ASDs.
- Further refinement of these techniques may lead to wider adoption and better patient outcomes in interventional cardiology.

